November 09, 2010 10:26
NPERC, Bayer to conduct joint research on biodegradable injection
Shanghai. November 9. INTERFAX-CHINA - The National Pharmaceutical Engineering Research Center (NPERC), a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI), has signed an agreement with German giant Bayer Schering Pharma AG to conduct joint research on a biodegradable injection drug delivery system, SIPI announced Nov. 8.
The announcement did not disclose the financial terms of the agreement.
NPERC is currently working on 10 different technologies for dosage preparation and drug delivery, including biodegradable microspheres, liposome preparations, a bioadhesive dosage form and an oral suspension sustained release system.
August 26, 2016
Outflow from funds investing in Russian equities $24.5 mln for week- EPFR
Russian investigators bring charges against man who seized bank in central Moscow (Part 2)
Uzbekistan, Kyrgyzstan agree to resolve disputed mount's problem - media
RUSSIAN AND JAPANESE DEFENSE MINISTRIES SEE PROSPECT FOR INTERACTION IN MULTILATERAL FORMATS IN ASIA-PACIFIC REGION - RUSSIAN DEPUTY DEFENSE MINISTER ANTONOV
RUSAGRO NET PROFIT DECLINES 44% TO 1.7 BLN RUBLES IN Q2 - COMPANY
RUSSIAN DEFENSE MINISTRY INFORMS JAPAN OF SURPRISE INSPECTION IN RUSSIAN ARMED FORCES
RUSSIAN DEPUTY DEFENSE MINISTER ANTONOV NOTES NEGATIVE IMPACT OF U.S. MISSILE DEFENSE ELEMENTS' DEPLOYMENT IN ASIA PACIFIC REGION ON REGIONAL SITUATION
RUSSIAN DEFENSE MINISTRY INVITES JAPANESE COLLEAGUES TO JOIN HUMANITARIAN OPERATION IN SYRIA'S ALEPPO
Coordinators of working groups on situation in Donbas meet in Minsk
Russian monetary base up 10 bln rubles
Some 1,000 Russian servicemen, 200 units of hardware in S. Ossetia taking part in surprise check - Russian Defense Ministry
RUSSIAN MONETARY BASE WAS AT 8733.7 BLN RUBLES ON AUGUST 19, UP FROM 8723.7 BLN RUBLES ON AUGUST 12 - CB
MICEX and RTS Indexes at 11:00 MSK
Tatneft posts IFRS net profit of 30.9 bln rubles, EBITDA of 45.3 bln rubles in Q2 (Part 2)